TERN

Terns Pharmaceuticals, Inc.

Sales chart range
Log in to watch TERN
Latest sale
$50k
Apr 1 · No plan
Form 4 sales
21
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleNo plan
    Oct 1 2025

    Sold 944 shares at $7.85 ($7k)

    Kuriakose Emil, Chief Medical Officer

    No 10b5-1 planSold 1.8% of holdings ($412k position)51,520 shares left1x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Nov 4 +34 days

    Sold 24,520 shares at $18.00 ($441k)

    Quigley Jill M., Director

    10b5-1 planSold 100% of holdings ($441k position)0 shares left1.6x usual sizeFiling

  3. 3 Form 4 saleNo plan
    Jan 2 +59 days

    Sold 1,155 shares at $38.57 ($45k)

    Kuriakose Emil, Chief Medical Officer

    No 10b5-1 planSold 2.2% of holdings ($2M position)50,365 shares left1.2x usual sizeFiling

  4. 4 Form 4 saleUnusual
    Jan 5 +3 days

    Sold 71,339 shares at $38.10 ($2.7M)

    Burroughs Amy L., Chief Executive Officer

    No 10b5-1 planSold 33.9% of holdings ($8M position)138,976 shares leftFirst sale on recordFiling

  5. 5 Form 4 saleRoutine
    Jan 15 +10 days

    Sold 68,749 shares at $37.08 ($2.5M)

    Burroughs Amy L., Chief Executive Officer

    10b5-1 planSold 19.2% of holdings ($13.3M position)288,976 shares leftFiling

  6. 6 Form 4 saleRoutine
    Feb 17 +33 days

    Sold 14,583 shares at $39.20 ($572k)

    Burroughs Amy L., Chief Executive Officer

    10b5-1 planSold 4.8% of holdings ($11.9M position)288,976 shares leftFiling

  7. 7 Form 4 saleRoutine
    Mar 16 +27 days

    Sold 14,583 shares at $46.71 ($681k)

    Burroughs Amy L., Chief Executive Officer

    10b5-1 planSold 4.8% of holdings ($14.2M position)288,976 shares left0.2x usual sizeFiling

  8. 8 Form 4 saleNo plan
    Apr 1 +16 days

    Sold 942 shares at $52.75 ($50k)

    Kuriakose Emil, Chief Medical Officer

    No 10b5-1 planSold 0.9% of holdings ($5.6M position)105,673 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (21)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for TERN
Source
Apr 1, 2026Kuriakose EmilChief Medical OfficerForm 4 sale942$50k0.9%No planSEC
Mar 16, 2026Burroughs Amy L.Chief Executive OfficerForm 4 sale14,583$681k4.8%RoutineSEC
Feb 17, 2026Burroughs Amy L.Chief Executive OfficerForm 4 sale14,583$572k4.8%RoutineSEC
Jan 15, 2026Burroughs Amy L.Chief Executive OfficerForm 4 sale68,749$2.5M19.2%RoutineSEC
Jan 5, 2026Burroughs Amy L.Chief Executive OfficerForm 4 sale71,339$2.7M33.9%UnusualSEC
Jan 2, 2026Kuriakose EmilChief Medical OfficerForm 4 sale1,155$45k2.2%No planSEC
Nov 4, 2025Quigley Jill M.DirectorForm 4 sale24,520$441k100.0%RoutineSEC
Oct 1, 2025Kuriakose EmilChief Medical OfficerForm 4 sale944$7k1.8%No planSEC
Jul 1, 2025Kuriakose EmilChief Medical OfficerForm 4 sale853$4k1.6%No planSEC
Apr 1, 2025Kuriakose EmilChief Medical OfficerForm 4 sale952$2k1.8%No planSEC
Jan 6, 2025Vignola Mark J.Chief Financial OfficerForm 4 sale17,188$99k18.7%RoutineSEC
Jan 6, 2025Quigley Jill M.DirectorForm 4 sale15,000$86k100.0%RoutineSEC
Jan 2, 2025Kuriakose EmilChief Medical OfficerForm 4 sale4,481$26k7.6%No planSEC
Sep 10, 2024Vignola Mark J.Chief Financial OfficerForm 4 sale10,000$110k9.8%RoutineSEC
Sep 9, 2024Quigley Jill M.DirectorForm 4 sale17,235$172k53.5%RoutineSEC
Aug 2, 2024Quigley Jill M.DirectorForm 4 sale15,000$114k50.0%RoutineSEC
Jul 16, 2024Quigley Jill M.DirectorForm 4 sale14,765$148k33.0%RoutineSEC
Jul 16, 2024Gordon Carl LDirector, 10% ownerForm 4 sale56,164$562k6.9%RoutineSEC
Jul 16, 2024OrbiMed Genesis GP LLCDirector, 10% ownerForm 4 sale56,164$562k6.9%RoutineSEC
Apr 3, 2024Vivo Opportunity, LLC10% ownerForm 4 sale420,663$2.8M61.0%RoutineSEC
Nov 23, 2022Oriental Spring Venture Ltd10% ownerForm 4 sale1.5M$8.3M73.9%UnusualSEC